BusPIRone Hydrochloride Tablets USP 7.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord H...

FDA Recall #D-0375-2023 — Class II — February 7, 2023

Recall #D-0375-2023 Date: February 7, 2023 Classification: Class II Status: Terminated

Product Description

BusPIRone Hydrochloride Tablets USP 7.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA, NDC 16729-201-01

Reason for Recall

CGMP Deviations: recalling drug products following an FDA inspection.

Recalling Firm

Accord Healthcare, Inc. — Durham, NC

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

23,784 bottles

Distribution

United States including Puerto Rico and Canada

Code Information

Batches: P2105532, Exp. Date 6/30/2024; P2200348, Exp. Date 12/31/2024;

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated